Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can early counseling help breast cancer survivors get back to work?

NCT ID NCT01780064

Symptom relief Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether early, personalized support from a psychologist could help women with breast cancer return to work more successfully than standard support. The study included 128 women who had surgery and chemotherapy. Unfortunately, the trial was stopped early, so we have limited information on how well it worked.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
interviews with a psychologist
What this could lead to
If this approach works, it could help women with breast cancer return to work more successfully by addressing emotional and social challenges early.
What could go wrong
The trial was terminated early, so results are limited. The benefit over standard support is uncertain, and individual outcomes may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Feb 2013

Finished

Jan 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women ≥ 18 with work at the time of diagnosis * Presenting a unilateral breast cancer exclusively local extension * Having received surgery * Reporting of adjuvant chemotherapy (+ / - trastuzumab) * Reporting to radiotherapy or not (If radiotherapy, it will be done on site investigator) * In work at the time of diagnosis (employees, traders and professionals) * Patient affiliated to a social security scheme * Consent signed by the patient before the implementation of any specific procedure to study Exclusion Criteria: * Presence of in situ lesions, cancer recurrence, metastatic disease immediately, location bilateral * Inability physical, psychological, psychiatric or cognitive responses to the questionnaires and participate in interviews * Recognition previous ALD (due to another disease) * Patient under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

Contacts and locations

Locations

  • Centre Hospitalier

    Valenciennes, 59300, France

  • Centre Léonard de Vinci

    Dechy, 59187, France

  • Centre Marie Curie

    Arras, 62000, France

  • Centre Oscar Lambret

    Lille, 59020, France

  • Centre Pierre Curie

    Beuvry, 62880, France

  • Hôpital Privé de Villeneuve d'Ascq

    Villeneuve-d'Ascq, 59657, France

  • Nouvelle Clinique des Dentellières

    Valenciennes, 59300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.